Gara Jalqabaatti › Kansarii Pancreas › Virginia › Arlington
Qorannoo klinikaalii Kansarii Pancreas Arlington, VA keessatti
Qorannoo 33 Kansarii Pancreas f Arlington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Vanguard Study: Testing a New Way to Screen for Cancer
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
- Inova Fair Oaks Hospital, Fairfax · Miili 11 fagaatti
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 3
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Virginia, Fairfax · Miili 11 fagaatti
A Study of PHN-012 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- PHN-012-001 Site, Fairfax · Miili 11 fagaatti
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Namoota walitti qabaa jiraSadarkaa 3
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 3
- Investigative Site US057, Fairfax · Miili 11 fagaatti
- Investigative Site US065, Fairfax · Miili 11 fagaatti
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · Miili 11 fagaatti
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Namoota walitti qabaa jiraSadarkaa 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · Miili 11 fagaatti
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT - Virginia, Fairfax · Miili 11 fagaatti
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology, Fairfax · Miili 11 fagaatti
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Namoota walitti qabaa jiraQorannoo ilaalaa
- Inova Fairfax Hospital, Falls Church · Miili 4 fagaatti
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
- Inova Fair Oaks Hospital, Fairfax · Miili 11 fagaatti
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Namoota walitti qabaa jiraSadarkaa 1
- Virginia Cancer Specialists, PC, Fairfax · Miili 11 fagaatti
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Inova Fairfax Hospital, Falls Church · Miili 4 fagaatti
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
- Inova Fair Oaks Hospital, Fairfax · Miili 11 fagaatti
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virginia, Fairfax · Miili 11 fagaatti
Pancreatic Cancer Early Detection Consortium
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virginia, Fairfax · Miili 11 fagaatti
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virginia, Fairfax · Miili 11 fagaatti
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Namoota walitti qabaa jiraSadarkaa 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · Miili 11 fagaatti
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Fairfax · Miili 11 fagaatti
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Virginia, Fairfax · Miili 11 fagaatti
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Namoota walitti qabaa jiraSadarkaa 3
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
- Inova Fair Oaks Hospital, Fairfax · Miili 11 fagaatti
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Namoota walitti qabaa jiraSadarkaa 1/2
- Next Oncology Virginia, Fairfax · Miili 11 fagaatti
A 2-part Phase 1/2 Open-label Trial on ODM-212
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Virginia, Fairfax · Miili 11 fagaatti
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Virginia, Fairfax · Miili 11 fagaatti
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT, Virginia, Fairfax · Miili 11 fagaatti
Qorannoo Kansarii Pancreas magaalota biroo keessatti
- Houston, TXQorannoo 61
- New York City, NYQorannoo 60
- Boston, MAQorannoo 43
- Nashville, TNQorannoo 39
- Los Angeles, CAQorannoo 35
- St. Louis, MOQorannoo 33
- Baltimore, MDQorannoo 31
- San Antonio, TXQorannoo 31
- Philadelphia, PAQorannoo 26
- Tampa, FLQorannoo 26
- Durham, NCQorannoo 24
- San Diego, CAQorannoo 24
Qorannoo biroo Arlington keessatti
- Kansara Qara'a Non-Small CellQorannoo 104
- Kansara MetastatikiiQorannoo 53
- Kansarii ColorectalQorannoo 52
- Saree (Gosoota Hunda)Qorannoo 48
- Saree OljooQorannoo 47
- Kansarii OvariiQorannoo 46
- Dhibee QaraQorannoo 41
- Kansa EndometiriyaaliiQorannoo 39
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 26
- Kansarii Hafuu Seli XiqqaaQorannoo 23
- Kanisa HarkaaQorannoo 20
- Kansaar Onnee Triple-NegativeQorannoo 20
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.